Merit Financial Group LLC bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 36,649 shares of the medical instruments supplier's stock, valued at approximately $548,000.
Other large investors have also recently modified their holdings of the company. Riverview Trust Co purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. Colonial Trust Co SC bought a new stake in DENTSPLY SIRONA during the fourth quarter worth about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares during the period. True Wealth Design LLC increased its stake in shares of DENTSPLY SIRONA by 866.7% during the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after purchasing an additional 1,950 shares in the last quarter. Finally, Quarry LP boosted its position in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Institutional investors own 95.70% of the company's stock.
DENTSPLY SIRONA Price Performance
Shares of NASDAQ XRAY traded up $0.19 during mid-day trading on Tuesday, reaching $16.42. The company's stock had a trading volume of 1,538,831 shares, compared to its average volume of 2,958,754. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $27.95. The stock has a fifty day moving average of $14.62 and a two-hundred day moving average of $16.92. The firm has a market capitalization of $3.27 billion, a PE ratio of -7.93, a P/E/G ratio of 1.80 and a beta of 0.95.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company's revenue was down 7.8% on a year-over-year basis. During the same period last year, the firm posted $0.42 EPS. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.90%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.10%.
Wall Street Analyst Weigh In
XRAY has been the subject of a number of analyst reports. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a report on Tuesday, April 15th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, UBS Group cut their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and an average target price of $20.36.
Check Out Our Latest Stock Analysis on XRAY
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
